Meta-Analysis the Effect of Pregnancy with Hepatitis B on Preterm Birth and Gestational Diabetes Mellitus


  • Alfi Zamilul Haniah Master’s Program in Public Health, Universitas Sebelas Maret
  • Uki Retno Budihastuti Department of Obstetric and Gynecology, Dr. Moewardi Hospital, Surakarta/ Faculty of Medicine, Universitas Sebelas Maret
  • Eti Poncorini Pamungkasari Faculty of Medicine, Universitas Sebelas Maret



Background: HBsAg positive pregnant women are responsible for around 50% of the global disease burden. Hepatitis B is caused by inflammation or infection of liver cells caused by the HBV virus. Pregnant women with hepatitis B can experience increased levels of cytokines which then cause pregnancy disorders. This study aims to examine the effect of pregnancy with hepatitis B on the incidence of preterm birth and Gestational Diabetes Mellitus (GDM).
Subjects and Method: This study is a meta-analysis study and a systematic review. The articles used were obtained from several electronic databases including PubMed, Science Direct, Research Gate, and Google Scholar. The articles used in this study were articles that have been published from 2012-2022. The keywords to search for articles are as follows Pregnancy AND (“Hepatitis B” OR HBV OR HBsAg) AND (“pregnancy outcome” OR “fetal outcome”) AND (“preterm birth” OR “preterm delivery” OR premature) AND (“gestational diabetes mellitus” OR GDM). The researched article is a complete text with an observational study design. Articles were collected using the PRISMA diagram, and analyzed using the Review Manager 5.4 application.
Results: A total of 14 prospective and retrospective cohort studies were analyzed. Articles were originated from China, Hong Kong, France and Botswana. Hepatitis B in pregnancy increased the risk of preterm birth (aOR=1.20; CI 95%=1.09 to 1.33; p<0.001) and gestational diabetes mellitus (aOR= 1.20; CI 95%= 1.12 to 1.28; p<0.001).
Conclusion: Hepatitis B in pregnancy increases the risk of preterm birth and GDM significantly.


Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, et al. (2018). HBV or HCV coinfection in HIV-1-infected pregnant women in France: prevalence and pregnancy outcomes. J Acquir Immune Defic Syndr. 77(5): 439-450. doi: 10.1097/QAI.0000000000001618.

Cai Q, Liu H, Han W, Liu L, Xu Y, He Y, Zheng Y (2019). Maternal HbSAg carriers and adverse pregnancy outcomes: a hospital‐based prospective cohort analysis. J Viral Hepat. 26(8): 1011–1018. doi: 10.1111/jvh.13105

Centers for Disease Control and Prevention. (2018). Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report, Recommendations and Reports. 67(1).

Chen J, Zhang S, Zhou Y, Xu B, Hu Y (2015). Minimal adverse influence of maternal hepatitis B carrier status on perinatal outcomes and child's growth. J Matern-Fetal Neonatal Med. 28(18): 2192-2196. doi: 10.3109/14767058.2014.981805

Cochrane (2014). RevMan 5.3 user guide.

Lao TT, Cheung M, Chung TKW, Law L (2016). Antenatal hepatitis B and increased risk of gestational diabetes mellitus e Implications for obstetric care. J infect. 72(5):625–626. doi: 10.1016/j.jinf.2016.02.007

Lao TT (2020). Hepatitis b-chronic carrier status and pregnancy outcomes: An obsteric perspective. Best Pract Res Clin Obstet Gynaecol. 68:66-77. doi: 10.1016/ j.bpobgyn.2020.03.006

Li C, Yang Y, Wang Y, Dong S, Yang Y, Shi Y, Li L et al. (2020). Impact of maternal HIV–HBV coinfection on pregnancy outcomes in an underdeveloped rural area of southwest China. Sex Transm Infect. 96(7):509-515. doi: 10.1136/sextrans2019054295

Ma X, Sun D, Li C, Ying J, Yan Y (2018). Chronic hepatitis B virus infection and preterm labor (birth) in pregnant women—an updated systematic review and meta-analysis. J Med Virol. 90(1): 93–100. doi: 10.1002/jmv.24927

Mbangiwa T, Pinkie M, Kesaobaka M, Motswedi A, Lynnette B, Sikhulile M, Bonol P et al. (2019). Maternal hepatitis B virus infection, pregnancy, and infant health outcomes in Botswana. Hepat Mon. 9(10): e95569. doi: 10.5812/hepatmon.95569

Mishra S, Purandre P, Thakur R, Agrawal S, Alwani M (2017). Study on prevalence of hepatitis B in pregnant women and its effect on maternal and fetal outcome at tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 6(6): 2238 -2240. doi: 10.18203/23201770.ijrcog20172069

Murti B, and Munawaroh SM, (2023). Penilaian Kritis (Critical Appraisal) Studi Kohor untuk Penelitian Meta-analisis. Sekolah Pascasarjana Prodi IKM UNS: Yayasan Karya Sains

Peng S, Wan Z, Lin X, Li X, Du Y (2019). Maternal hepatitis B surface antigen carrier status increased the incidence of gestational diabetes mellitus. BMC Infect Dis. 19(1):147. doi: 10.1186/s1287901937491

Tan J, Liu X, Mao X, Yu J, Chen M, Li Y, Sun X (2016). HBsAg positivity during pregnancy and adverse maternal outcomes: a retrospective cohort analysis. J Viral Hepat. 23(10):812-819. doi: 10.1111/jvh.12545

Tan J, Huang S, He G, Tang L, Ren Y, Zheng J, Liu X et al. (2017). Maternal hepatitis B surface antigen carrier status and its impact on neonatal outcomes: a cohort study of 21 947 singleton newborns in China. J Matern Fetal Neonatal Med. 30(18):2219–2224. doi: 10.1080/14767058.2016.1243098

World Gastroenterology Organisation (2015). Global Guideline Hepatitis B Versi 2.0. hepatitis-b-english-2015.pdf

World Health Organization (2022). Key facts hepatitis B. World Health Organization.

Wu K, Wang H, Li S, Zhang H, Zhu B (2020). Maternal hepatitis B infection status and adverse pregnancy outcomes: a retrospective cohort analysis. Arch Gynecol Obstet. 302(3):595-602. doi: 10.1007/s00404020056302

Xiong Y, Liu C, Huang S, Wang J, Qi Y, Yao G, Sun W et al. (2021). Impact of maternal infection with hepatitis B virus on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology treatment: a population-based study. J Viral Hepat. 28: 613-620. doi: 10.1111/jvh.13472

Xu C, Bao Y, Zuo J, Li Y., Tang Y, Qu X, Ying H (2021). Maternal chronic hepatitis B virus infection and the risk of preterm birth: a retrospective cohort analysis in Chinese women. J Viral Hepat. 28(10): 1422–1430. doi: 10.1111/jvh.13585

Yin W, Chen B, Yang Y, Li X, Li R, Xie J, Chen G et al. (2021). Association between maternal hepatitis B virus carrier and gestational diabetes mellitus: a retrospective cohort analysis. Virol J. 18(1):1–9. doi: 10.1186/s12985021016910

Yu M, Jiang Q, Gu X, Ju L, Ji Y, Wu K, Jiang H (2013). Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta. PLoS ONE. 8(1): e5424. doi: 10.1371/journal.pone.0054246

Zhao Y, Chen Y, Song H., Huang P, Wang L, Liu W, Huang B et al. (2020). Effects of maternal hepatitis B surface antigen positive status on the pregnancy outcomes: a retrospective study in Xiamen, China, 2011-2018. PLoS ONE. 15(3):e0229732. doi: 10.1371/journal.pone.0229732

Zheng S., Zhang H, Chen R, Yan J, Han Q (2021). Pregnancy complicated with hepatitis B virus infection and preterm birth: a retrospective cohort study. BMC Pregnancy and ChildB. 21(1):1–8. doi: 10.1186/s12884021039780.




How to Cite

Haniah, A. Z., Budihastuti, U. R., & Pamungkasari, E. P. (2024). Meta-Analysis the Effect of Pregnancy with Hepatitis B on Preterm Birth and Gestational Diabetes Mellitus. Journal of Maternal and Child Health, 9(1), 1–13.